Ledaga
Ledaga is a medicine authorised by Swissmedic under authorisation number 67615. The authorisation holder is RECORDATI AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 September 2021 and the authorisation is valid without a time limit. ATC code L01AA05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67615 |
|---|---|
| Name | Ledaga |
| Full name | Ledaga, Gel |
| Authorisation holder | RECORDATI AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01AA05 |
| First authorisation | 28 September 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ledaga, Gel | A | 28 September 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | g | L01AA05 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ledaga authorised in Switzerland?
Yes. Ledaga is authorised by Swissmedic under authorisation number 67615, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ledaga have?
Ledaga is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ledaga?
The authorisation holder is RECORDATI AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.